stanozolol Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: Vendor-neutral scientific reference catalog record for stanozolol

synthetic anabolic-androgenic steroid compound Reference needs_revision Best effort · source review pending

Also known as: Winstrol, Androstanazol, Androstanazole, Win 14833, Stanozololum, Estanozolol, Stromba

Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.

Quick Facts

Reference Sizes
Not standardized / source review pending

Best-Effort Research Profile

Stanozolol is a synthetic anabolic-androgenic steroid and androgen. Its standardized chemical identity is associated with CAS RN 302-96-5, PubChem CID 25249, FDA GSRS UNII 4R1VB9P8V3, and InChIKey LKAJKIOFIWVMDJ-IYRCEVNGSA-N. It has been used in research and clinical contexts involving anabolic activity and hereditary angioedema, and is listed by U.S. federal regulation in oral veterinary dosage forms. Human and veterinary uses, regulatory status, and available formulations are jurisdiction- and product-specific.

Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.

Research Profile

Administration Routes (Research)
oral

Reported Research Effects

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Notes

Common reference sizes were not populated because a universally applicable scientific/catalog size convention was not established from authoritative sources. Pharmacokinetic half-life and onset were left blank because available authoritative evidence identified in this review was not sufficiently consistent and route- or species-specific data should not be generalized. The cited federal regulation concerns veterinary oral dosage forms and should not be interpreted as a general human dosing recommendation.

Supplementary research context only. Not medical advice or a treatment recommendation.

Registry Identifiers

Molecular formula: C21H32N2O; molecular weight: 328.5 g/mol; CAS RN: 302-96-5; PubChem CID: 25249; FDA GSRS UNII: 4R1VB9P8V3; ChEBI: CHEBI:9249; ChEMBL: CHEMBL2079587; InChIKey: LKAJKIOFIWVMDJ-IYRCEVNGSA-N; IUPAC name: (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol.

Source-Backed Observations

PubChem classifies stanozolol as an anabolic agent, androgen, and anabolic-androgenic steroid. U.S. federal regulations describe 2 mg oral stanozolol tablets for veterinary use in dogs and cats. Stanozolol is included among prohibited anabolic agents under the World Anti-Doping Code Prohibited List.

Reflects published research. Educational reference — not a recommendation for use.

Sources Under Review

Stanozolol | CID 25249
https://pubchem.ncbi.nlm.nih.gov/compound/25249 (accessed 2026-09-15)
STANOZOLOL FDA GSRS Substance Record
https://precision.fda.gov/uniisearch/srs/unii/4R1VB9P8V3 (accessed 2026-09-15)
Metabolism of stanozolol: identification and synthesis of urinary metabolites
https://pubmed.ncbi.nlm.nih.gov/2362445/ (accessed 2026-09-15)

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top